115 related articles for article (PubMed ID: 32358087)
1. NEMESIS: Noninferiority, Individual-Patient Metaanalysis of Selective Internal Radiation Therapy with
Venerito M; Pech M; Canbay A; Donghia R; Guerra V; Chatellier G; Pereira H; Gandhi M; Malfertheiner P; Chow PKH; Vilgrain V; Ricke J; Leandro G
J Nucl Med; 2020 Dec; 61(12):1736-1742. PubMed ID: 32358087
[TBL] [Abstract][Full Text] [Related]
2. Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma.
Feng X; Zhang L; Niu H; Zhang H; Yang L; Wen Y; Chen SY; Shi Y; He Z; Yu L; Wang Y; Huang X; Wang Z; Qin M; Wen X; Zhang Z; Song J; Zheng Z; Yin H; Zhang H; Ma L; Wei J; Wu X; Zhang L; Zhao Y; Lu Q; Xiao H; Liu T; Fang P; Wei L; Gandhi RT; Dong J
Asia Pac J Clin Oncol; 2024 Apr; 20(2):319-322. PubMed ID: 36658669
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of platelet-to-lymphocyte and neutrophil-to-lymphocyte ratio in HCC treated with sorafenib and radioembolization.
Öcal O; Kimm MA; Hoang TPT; Pech M; Öcal E; Ben Khaled N; Sangro B; Ricke J; Seidensticker M; Wildgruber M
JHEP Rep; 2024 Apr; 6(4):100995. PubMed ID: 38440069
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Selective Internal Radionuclide Therapy with
Bellendorf A; Mader N; Mueller SP; Ezziddin S; Bockisch A; Grafe H; Best J; Goebel J; Pöppel TD; Sabet A
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256934
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.
Garin E; Tselikas L; Guiu B; Chalaye J; Rolland Y; de Baere T; Assenat E; Tacher V; Palard X; Déandreis D; Mariano-Goulart D; Amaddeo G; Boudjema K; Hollebecque A; Meerun MA; Regnault H; Vibert E; Campillo-Gimenez B; Edeline J
J Nucl Med; 2024 Feb; 65(2):264-269. PubMed ID: 38212068
[TBL] [Abstract][Full Text] [Related]
6. Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registry.
Lee RC; Liang PC; Liang HL; Chen YF; Yu CY; Cheng PN; Hung CF; Hsia CY; Lai HC; Ho MC; Cheng YF; Liu YS; Chao Y; Chen CH
J Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38615197
[TBL] [Abstract][Full Text] [Related]
7. [Expert consensus on the standardized procedure of selective internal radiation therapy with Yttrium-90 microspheres for liver malignancies (2024 edition)].
;
Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(7):486-498. PubMed ID: 38317360
[TBL] [Abstract][Full Text] [Related]
8. Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany.
Thoduka SG; Flegar L; Groeben C; Huber J; Eisenmenger N; Paulus T; Vogt K; Luster M; Abolmaali N
Curr Oncol; 2023 Dec; 30(12):10325-10335. PubMed ID: 38132386
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients.
Saalfeld S; Kreher R; Hille G; Niemann U; Hinnerichs M; Öcal O; Schütte K; Zech CJ; Loewe C; van Delden O; Vandecaveye V; Verslype C; Gebauer B; Sengel C; Bargellini I; Iezzi R; Berg T; Klümpen HJ; Benckert J; Gasbarrini A; Amthauer H; Sangro B; Malfertheiner P; Preim B; Ricke J; Seidensticker M; Pech M; Surov A
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2301-2309. PubMed ID: 37592827
[TBL] [Abstract][Full Text] [Related]
10. Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma.
Wang EA; Broadwell SR; Bellavia RJ; Stein JP
J Gastrointest Oncol; 2017 Apr; 8(2):266-278. PubMed ID: 28480066
[TBL] [Abstract][Full Text] [Related]
11. 177 Lu-Microspheres Selective Intra-arterial Radionuclide Therapy : A Facile and Biocompatible Permanent Micro-Seed Implants for Unresectable Hepatocellular Carcinoma.
Shukla J; Chopra S; Kaur K; Chakraborty S; Singh H; Duseja A; Kalra N; Mittal BR
Clin Nucl Med; 2024 Apr; 49(4):e170-e171. PubMed ID: 38377367
[TBL] [Abstract][Full Text] [Related]
12. Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials.
Tan DJH; Tang ASP; Lim WH; Ng CH; Nah B; Fu C; Xiao J; Koh B; Tay PWL; Tan EX; Teng M; Syn N; Muthiah MD; Tamaki N; Lee SW; Kim BK; Yau T; Vogel A; Loomba R; Huang DQ
Liver Cancer; 2023 Oct; 12(5):445-456. PubMed ID: 37901764
[TBL] [Abstract][Full Text] [Related]
13. Anatomical Quantitative Volumetric Evaluation of Liver Segments in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy: Key Parameters Influencing Untreated Liver Hypertrophy.
Girardet R; Knebel JF; Dromain C; Vietti Violi N; Tsoumakidou G; Villard N; Denys A; Halkic N; Demartines N; Kobayashi K; Digklia A; Schaefer N; Prior JO; Boughdad S; Duran R
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339337
[No Abstract] [Full Text] [Related]
14. Is the Concurrent Use of Sorafenib and External Radiotherapy Feasible for Advanced Hepatocellular Carcinoma? A Meta-Analysis.
Rim CH; Park S; Shin IS; Yoon WS
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200809
[TBL] [Abstract][Full Text] [Related]
15. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.
Kennedy A; Brown DB; Feilchenfeldt J; Marshall J; Wasan H; Fakih M; Gibbs P; Knuth A; Sangro B; Soulen MC; Pittari G; Sharma RA
J Gastrointest Oncol; 2017 Dec; 8(6):1079-1099. PubMed ID: 29299370
[TBL] [Abstract][Full Text] [Related]
16. Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and review.
Kim JH; Kim BJ; Jang HJ; Lee J
Oncotarget; 2017 Nov; 8(60):102321-102327. PubMed ID: 29254247
[TBL] [Abstract][Full Text] [Related]
17. Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma.
Ricke J; Steffen IG; Bargellini I; Berg T; Bilbao Jaureguizar JI; Gebauer B; Iezzi R; Loewe C; Karçaaltincaba M; Pech M; Sengel C; van Delden O; Vandecaveye V; Zech CJ; Seidensticker M
JHEP Rep; 2020 Dec; 2(6):100173. PubMed ID: 33103093
[TBL] [Abstract][Full Text] [Related]
18. Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.
Walton M; Wade R; Claxton L; Sharif-Hurst S; Harden M; Patel J; Rowe I; Hodgson R; Eastwood A
Health Technol Assess; 2020 Sep; 24(48):1-264. PubMed ID: 33001024
[TBL] [Abstract][Full Text] [Related]
19. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Garin E; Tselikas L; Guiu B; Chalaye J; Edeline J; de Baere T; Assenat E; Tacher V; Robert C; Terroir-Cassou-Mounat M; Mariano-Goulart D; Amaddeo G; Palard X; Hollebecque A; Kafrouni M; Regnault H; Boudjema K; Grimaldi S; Fourcade M; Kobeiter H; Vibert E; Le Sourd S; Piron L; Sommacale D; Laffont S; Campillo-Gimenez B; Rolland Y;
Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):17-29. PubMed ID: 33166497
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
